Biggest News Aggregation in the World
📰 Nasdaq Coll News

Page 3 - Nasdaq Coll News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Nasdaq Coll. Real-time updates on events, politics, business and more.

Gladius Capital Management LP Sells 478 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)

Gladius Capital Management LP cut its stake in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 27.9% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,235 shares of the specialty pharmaceutical company’s stock after selling 478 shares during the […]
United Kingdom Piper Sandler Joseph Ciaffoni Shirleyr Kuhlmann Collegium Pharmaceutical Inc Marshall Wace

Collegium Pharmaceutical's (COLL) Neutral Rating Reiterated at HC Wainwright

HC Wainwright reissued their neutral rating on shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) in a report issued on Friday morning, Benzinga reports. Several other analysts have also commented on COLL. Needham & Company LLC reaffirmed a buy rating and set a $35.00 price target on shares of Collegium Pharmaceutical in a research report […]
Los Angeles United States Piper Sandler Joseph Ciaffoni Shirleyr Kuhlmann Principal Financial Group Inc

Collegium Pharmaceutical (NASDAQ:COLL) Trading Up 4.9%

Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report)’s share price was up 4.9% during trading on Monday . The stock traded as high as $25.02 and last traded at $24.64. Approximately 108,557 shares traded hands during trading, a decline of 73% from the average daily volume of 396,780 shares. The stock had previously closed at […]
Los Angeles United States Shirleyr Kuhlmann Joseph Ciaffoni Piper Sandler Needham Company
Source: wkrb13.com

30,388 Shares in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Purchased by ProVise Management Group LLC

ProVise Management Group LLC purchased a new stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 30,388 shares of the specialty pharmaceutical company’s stock, valued at approximately $729,000. ProVise Management Group LLC owned about 0.09% of […]
Joseph Ciaffoni Piper Sandler Shirleyr Kuhlmann Provise Management Group Altshuler Shaham Ltd Financial Services Group Inc

Collegium Pharmaceutical (NASDAQ:COLL) Raised to "Buy" at StockNews.com

StockNews.com upgraded shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) from a hold rating to a buy rating in a report released on Wednesday. Several other equities analysts have also commented on COLL. Piper Sandler lowered their target price on Collegium Pharmaceutical from $37.00 to $35.00 in a report on Tuesday, April 25th. Needham & […]
Los Angeles United States Shirleyr Kuhlmann Joseph Ciaffoni Piper Sandler Needham Company

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Needham & Company LLC Reaffirms Buy Rating for Collegium Pharmaceutical (NASDAQ:COLL)

Collegium Pharmaceutical (NASDAQ:COLL – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at Needham & Company LLC in a research report issued on Friday, Benzinga reports. They presently have a $35.00 price objective on the specialty pharmaceutical company’s stock. Needham & Company LLC’s price objective would suggest a potential upside of […]
Shirleyr Kuhlmann Piper Sandler Joseph Ciaffoni Wealthplan Investment Management Altshuler Shaham Ltd Financial Services Group Inc
Source: wkrb13.com

Emerald Mutual Fund Advisers Trust Trims Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)

Emerald Mutual Fund Advisers Trust decreased its holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 1.3% in the 1st quarter, Holdings Channel reports. The firm owned 677,160 shares of the specialty pharmaceutical company’s stock after selling 8,733 shares during the period. Emerald Mutual Fund Advisers Trust’s holdings in Collegium Pharmaceutical were worth $16,245,000 […]
Piper Sandler Shirleyr Kuhlmann Joseph Ciaffoni Collegium Pharmaceutical Inc Altshuler Shaham Ltd Financial Services Group Inc

Foundry Partners LLC Invests $3.27 Million in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)

Foundry Partners LLC acquired a new position in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 136,480 shares of the specialty pharmaceutical company’s stock, valued at approximately $3,274,000. Foundry […]
United Kingdom Shirleyr Kuhlmann Joseph Ciaffoni Piper Sandler Collegium Pharmaceutical Inc Foundry Partners

Collegium Pharmaceutical (NASDAQ:COLL) Downgraded by StockNews.com

StockNews.com lowered shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) from a buy rating to a hold rating in a research report report published on Monday morning. Several other analysts also recently weighed in on the company. Needham & Company LLC restated a buy rating and set a $35.00 target price on shares of Collegium […]
Shirleyr Kuhlmann Joseph Ciaffoni Piper Sandler Securities Exchange Commission Jpmorgan Chase Co Brandywine Global Investment Management
Source: wkrb13.com

Insider Selling: Collegium Pharmaceutical, Inc. (NASDAQ:COLL) EVP Sells 17,984 Shares of Stock

Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) EVP Shirley R. Kuhlmann sold 17,984 shares of Collegium Pharmaceutical stock in a transaction dated Monday, June 26th. The shares were sold at an average price of $21.72, for a total transaction of $390,612.48. Following the transaction, the executive vice president now directly owns 119,518 shares of the […]
United States Shirleyr Kuhlmann Piper Sandler American Century Companies Inc Collegium Pharmaceutical Inc Needham Company

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science